conclusions AA ethnicity, female gender and attending a publicly funded primary care clinic were associated with lower adherence. Whether targeting these groups for special interventions would improve overall adherence needs further study.
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Nonadherence to medications is an important patient-related cause of poor blood pressure control 1, 2 contributing to disease progression, avoidable hospitalizations, disability and death. 3 In a World Health Organization report adherence to antihypertensive medications ranged from 52 to 74%. 4 Identifying which patient groups are at greater risk for poor adherence may assist in developing tailored interventions to increase medication adherence and improve outcomes. The results from studies assessing antihypertensive medication adherence in primary care compared with hospital settings are more generalizable to the overall population. 5 The available studies on patient-related predictors of adherence in primary care found African-American (AA) ethnicity, 6-8 depression 8 and caring for dependents 7 to be independently related to poor antihypertensive medication adherence. However, most of these studies used self-reported measures 6, 7 or pharmacy databases 8 to measure adherence. The most valid measurement of patients' adherence is monitoring with electronic devices such as the Medication Event Monitoring System (MEMS). 9, 10 In this study, we identified predictors of antihypertensive medication adherence measured by MEMS in uncontrolled hypertensives from large urban public and private primary care clinics.
Methods
Study population. This study is a cross-sectional analysis of a subset of patients in a cluster-randomized trial designed to test the hypothesis that reducing physician uncertainty would counteract clinical inertia and lead to improved blood pressure control. The details of the trial have been reported previously. 11 The study was conducted in 10 primary care clinics representing a public health-care delivery system and a private practice network in a large, urban area. By design, AAs comprised 60% of the study population. The clinics were randomized to intervention and control conditions in a 1:1 ratio after stratification by health system. Briefly, the intervention consisted of providing 24-h ambulatory blood pressure Background Most studies on patient-related predictors of adherence used selfreported measures or pharmacy databases to measure adherence. We identified predictors of antihypertensive medication adherence measured by Medication Event Monitoring System (MEMS), the gold standard for adherence assessment, in uncontrolled, predominantly African-American (AA) hypertensives from large urban public and private primary care clinics.
As part of the baseline data collection of a cluster-randomized trial for hypertension control, we measured adherence in a random sample of 124 participants using MEMS caps. We also included the data of 52 patients in intervention clinics who subsequently completed MEMS monitoring on referral from their provider. Participants were classified as adherent if they took ≥80% of all prescribed doses. Multivariate logistic regression was used to predict adherence. monitoring, electronic bottle cap monitoring of medication adherence, along with lifestyle assessment and counseling of patients. Physicians were free to decide which patients needed monitoring and/or counseling, and could order any combination of the intervention tools at any time during the study follow-up period. Recruitment began in January 2006 and was completed in March 2007. Eligible patients had to be over 21 years and have at least two clinic visits in the previous 12 months, with blood pressure on the most recent two consecutive visits of ≥140 mm Hg systolic or ≥90 mm Hg diastolic, or if diabetic, ≥130 mm Hg systolic or 80 mm Hg diastolic. Since the trial was aimed at improving blood pressure control in established hypertensives, some evidence of prior diagnosis and/or treatment of hypertension was required. Research assistants identified potential study participants by screening the medical records of patients who presented for a routine primary care appointment. Patients with cognitive impairment, renal insufficiency, or a serious concomitant illness such as cancer, recent myocardial infarction, or unstable angina, were excluded. Informed consent was obtained from both the patient and provider.
results

Of
Data on age, sex, race/ethnicity, employment status, and years of education completed were collected at baseline.
A random subsample of patients at baseline was offered an electronic bottle cap monitoring. The recruitment goal for the substudy was ~20% of the entire study sample, or 134 patients. The Aardex MEMS (MEMS 6 Track Cap) was used to record the date and time of each bottle cap opening during the monitoring period. Up to three antihypertensive medications were monitored for 30 days. Standardized quality control procedures included testing each device before it was dispensed to the participant (e.g., checking battery status, visually examining the devices for defects and malfunctions etc.), educating participants in the proper use of the devices, debriefing participants when they return devices, cleaning, and analyzing the data. 10 Of 248 patients randomly selected to participate in MEMS monitoring substudy, 154 agreed. The principal reasons for declining to participate in the substudy were lack of time and perceived inconvenience of the procedures. Of these 154 patients, 124 completed MEMS bottle cap monitoring as part of the baseline data collection of a trial. During follow-up in the intervention clinics, an additional 52 patients not included in the baseline sample completed MEMS monitoring on referral from their provider, and we included their data in our study. For the 11 patients in the intervention clinics who had been randomly selected for the baseline MEMS substudy, we used only the baseline data.
For each medication, we calculated the percentage of prescribed doses taken each day during the 30-day period. We averaged this number over all 30 days to estimate the average percentage of prescribed doses taken per day. This MEMSderived measure of adherence has been shown to be highly correlated with the mean percentage of days taken as prescribed. 12 For participants who had more than one monitored medication, we averaged this value across all medications.
Using a widely accepted definition, participants were classified as nonadherent if they took <80% of all prescribed doses, averaged across all monitored antihypertensives. 13, 14 Statistical methods. Analyses were performed by multivariate logistic regression with compliance as a dependent variable and including factors which had a P value of <0.20 in univariate analyses. Factors were regarded as significant in multivariate analyses when they had a P value of <0.05. Nonsignificant factors from the multivariate analyses were deleted from the model stepwise. Possible interactions between factors found to be significant in the multivariable analyses were tested. Data were analyzed using SPSS (version 19) for Windows (SPSS, Chicago, IL).
results
There were 665 patients in the baseline sample of the clinical trial. In this study, we included 176 patients who completed MEMS monitoring (including 124 patients randomly selected at baseline and 52 patients who were referred for monitoring by their physicians in the intervention clinics). Table 1 shows characteristics of these 176 patients. The mean systolic blood pressure (average of most recent two visits) was 153.1 ± 15.0 mm Hg and mean diastolic blood pressure was 84.8 ± 12.1 mm Hg. Mean number of antihypertensives in regimen was 2.6 ± 1.2. In general, all characteristics of the monitored sample were similar to those of the 665 patients enrolled in the clinical trial.
Of those monitored, 61 (34.6%) took <80% of prescribed doses. Table 1 shows the results of the univariate and multivariate analyses. In the final multivariate model, AA ethnicity was associated with lower adherence in comparison with Hispanic ethnicity. (odds ratio (OR) 0.36; (95% confidence interval (CI) 0.15-0.86). Female sex was another factor related to lower adherence (OR 0.38; 95% CI 0.15-0.91). Public clinic patients were less likely to be adherent to medications compared with private clinic patients (OR 0.45; 95% CI 0.20-0.97). Patients who were monitored by clinician order in the intervention clinics were more likely to be adherent compared with patients from the baseline random sample (2.15; 95% CI 0.96-4.81, borderline significant)). Diabetic patients were also more likely to be adherent (2.05; 95% CI 1.01-4.15). No statistical interaction was found between the predictors of adherence in the multivariate analyses.
discussion
To the best of our knowledge, this is the largest study in a predominantly AA sample on the predictors of antihypertensive medication adherence measured by MEMS, the gold standard for adherence assessment, and the first to compare health-care systems and to include other ethnic groups. Our study is in line with other studies showing that medication adherence is lower in hypertensive AAs compared with other ethnic groups. [6] [7] [8] 15 Thirty three percent of AAs were nonadherent in private clinics and 48% in public clinics, compared to 25% and 19 % of Hispanics (reference group), respectively.
The only other study using MEMS caps in an AA sample of low socioeconomic status found an interaction between education and medication adherence by sex. 12 Lower education was related to higher adherence among men, but lower adherence among women. We did not find a differential effect of education in men and women observed in that study, which included only 70 participants, suggesting that the finding is not consistent.
In a recent survey including Medicare recipients, elderly AAs followed physician instructions on how to take medications less frequently than did elderly whites, even after adjusting for differences in demographic characteristics, including income, prescription drug coverage, health literacy, depression, and social support. 6 In our study, the mean adherence rate of 57% in AAs was similar to the MEMS-measured baseline adherence of 56% in a practice-based trial among AAs, 16 suggesting that our findings are not atypical for AAs in primary care. Further investigation of underlying reasons for lower adherence among AA population may assist in developing tailored interventions to increase medication adherence.
In addition to AA participants, females and public clinic patients were less likely to be adherent to medications. Diabetic patients and those who were monitored by clinician order in the intervention clinics were more likely to adhere to medications.
Previous studies exploring the effect of sex on hypertensive medication nonadherence have conflicting results. Poor medication adherence was more common among men in a survey performed in a clinic serving primarily uninsured/underinsured black women. 7 However, women were less likely to fill a first prescription for antihypertensive medications in another study. 2 Our study is novel because it is first to identify predictors of MEMS-measured adherence in a socieconomically and ethnically diverse sample of hypertensives and to show that public clinic patients are less likely to be adherent to medications than private clinic patients. Public clinics serve predominantly minority patients and have more challenging workplaces and more medically and psychosocially complex patients. 17 We also found that patients monitored by clinician order in the intervention clinics were more likely to adhere to medications than patients randomly selected at baseline. Although only borderline significant, the increased odds of compliance in the intervention sample suggest the possibility that patients increased their adherence if their monitoring was ordered by their primary care provider. The possibility that patients increase their adherence during electronic bottle cap monitoring has been reported by Denhaerynck et al. 18 However, another study suggested that electronic bottle cap monitoring has no effect on adherence. 19 In our study, there was no interaction between any of the independent variables and probability of clinical referral, therefore, the observed predictors of adherence can be assumed to apply in both samples.
We also found diabetic patients to be more adherent to antihypertensive medications. This may imply the greater motivation to be adherent with therapy among patients who have multiple cardiovascular risk factors.
In our study, age was not associated with medication adherence. Previous studies exploring the effect of age on hypertensive medication nonadherence have conflicting results. Younger age has been found to be associated with poor adherence. 8 However, in a prescription claims database study older patients were significantly less likely to fill a first prescription for an antihypertensive medication compared with patients who were 10 years younger. 2 In another study, age was not associated with antihypertensive medication adherence. 12 The number of monitored medications was not associated with adherence in our study. The lack of association between the number of medications taken and adherence is not unexpected, since the findings of other investigations of this topic have been inconsistent. 20 A limitation of our study is that the estimates of adherence obtained in our study may underestimate the true prevalence rate of nonadherence. Although electronic bottle cap monitoring has been considered the gold standard for adherence assessment it has been shown to yield higher adherence rates than refill data. The MEMS monitoring in our study documented disruptions in taking prescriptions that had been filled, and did not address possible nonadherence arising from financial or other barriers to filling prescriptions. Another limitation is that we did not assess the effect of attitudinal factors on medication adherence.
In conclusion, we identified several predictors of medication adherence measured by MEMS, which is considered the gold standard for adherence assessment, in a socioeconomically and ethnically diverse sample of hypertensives. AA ethnicity, female gender and attending a publicly funded primary care clinic were associated with lower adherence. Whether targeting these groups for special interventions would improve overall adherence needs further study.
